CVS Caremark Corp: Company Report
One CVS Drive
Woonsocket RI 02895
http://info.cvscaremark.com/ - Phone: 401-7651500
- Fax: 401-7622137
- Industry : Drug Stores
- Employees : 215,000
- Exchange : NYSE
CVS Caremark Corporation (CVS Caremark) is a provider of prescriptions and related healthcare services in the United States. It is a pharmacy services company and drives value for its customers through its approximately 6,900 CVS/pharmacy and Longs Drug retail stores; CVS Caremark’s pharmacy benefit management, mail order and specialty pharmacy division, Caremark Pharmacy Services; its retail-based health clinic subsidiary, MinuteClinic, and Its online pharmacy, CVS.com. The Company operates in two business segments: Pharmacy Services and Retail Pharmacy. October 20, 2008, CVS Caremark acquired Longs Drug Stores Corporation, which includes 529 retail drug stores (the Longs Drug Stores) and RxAmerica LLC (RxAmerica), which provides pharmacy benefit management services, and certain other related assets.
| Stock Activity |
|---|
|
Last Price |
31.53 |
|
52 Week High |
38.27 |
|
52 Week Low |
23.74 |
|
Volume |
12.35 Mil |
|
Average Daily Volume (13wk) |
16.27 Mil |
|
50 Day Moving Average |
34.64 |
|
200 Day Moving Average |
31.94 |
|
Volatility (beta) |
0.70 |
| Stock Price History |
|---|
| | Change | Relative Strength |
|---|
|
Last 3 Months |
-14.3% |
22 |
|
Last 6 Months |
5.8% |
41 |
|
Last 12 Months |
11.4% |
37 |
Historical charts
| Institutional Statistics |
|---|
| Analyst Consensus | Moderate Buy | | Institutional Ownership | 83.50% |
More Analyst Ratings
Want to learn how to evaluate a stock? Walk through the steps using the Research Wizard. | advertisement
| Financials |
|---|
| | Last 12 Months | 5 Year Growth |
|---|
|
Sales |
97.0 Bil |
26.9% |
|
Income |
3.6 Bil |
31.9% |
|
Dividend Rate |
0.31 |
17.54% |
|
Dividend Yield |
0.97% |
0.60% |
More financials
| Fundamental Data |
|---|
| Debt/Equity Ratio | 0.34 | | Gross Margin | 20.64% | | Net Profit Margin | 3.72% | | Total Shares Outstanding | 1.4 Bil | | Market Capitalization | 44.47 Bil | | Earnings/Share | 2.46 |
More financial ratios
| Earnings Estimates
|
|---|
| Qtr(12/09) EPS Estimate |
0.78 |
| FY(12/09) EPS Estimate |
2.62 |
| Current P/E |
12.80 |
| FY(12/10) EPS Estimate |
2.78 |
| Forward P/E |
11.34 |
| Next Earnings Release:
N/A | | More analyst estimates
|
Recent News